Voyager Therapeutics’ chief and founder Steven Paul, M.D., is stepping down to become an “executive science advisor.” Paul is an Eli Lilly veteran who has been with the company since its inception six years ago, initially as president of R&D, then as president and CEO since September 2014.
Name: Steven Paul
Continent: North America
Company: Voyager Therapeutics
Announcement Date: January 31, 2018, 11:00pm
Resignation Date: January 31, 2018, 11:00pm